Clinical trial
Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study
NCT02489773 is registered in ClinicalTrials.gov with Asahi Kasei Therapeutics Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study
- Lead sponsor
- Asahi Kasei Therapeutics Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- July 31, 2016
- Enrollment
- 150 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes